Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of March 22, 2026

By / March 25, 2026

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

TAVALISSE (fostamatinib disodium)

Rigel pharms Patent: 7,538,108 Expiration: Mar 28, 2026

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

March-In Rights: The Dormant Nuclear Option That…
Drug Formulation Stability for Business Development:…
Why Orange Book Expiration Dates Don’t Match Real…
Predict your competitor’s next settlement
Win the Generic Pricing War: Strategies for Pricing…
Patent vs. Regulatory Exclusivity The Critical…
Master FDA Orange Book Codes to Predict Generic Drug…
Regulatory & Legal Service Firm Business…
Profit From Weak Drug Patents: Identifying Weak…
The Drug Patent Cliff Blind Spot: Why Your BD Team…
Build a Live Drug Patent LOE Dashboard Your…
Stop the Clock: How Divisional Patents Block Cheaper…
Sell To Pharma Using Patent Timelines
Biopharma Packaging: Use LOE waves to forecast…
Unlocking the Potential of Abandoned and Expired…
The Uncoupling of Device and Drug: A Strategic…
Mine the Orange Book: How FDA Drug Patent Data…
Patent Expiration Dates: The Calendar Every…
Buying Smart: The No-Nonsense Guide to Pharma Procurement
The Global Generic Drug Market: Trends,…
Uncovering the Hidden Financial, Strategic, and…
How to Evaluate CDMO Performance: The Definitive…
A Pharma Exec's Guide to Preliminary…
Why Your Generic Drug Launch Forecast Is Wrong…

Read the Drug Patent Clock Before the Market Does: A step-by-step technical guide to forecasting pharmaceutical drug patent expiry for IP teams, R&D strategists, and institutional investors

Pharm to Table: Map Supply Chains and Predict Drug Shortages Using Patent Data

Related Posts

Drug Patent Expirations for the Week of January 4, 2026

Patent Expiration / By

Drug Patent Expirations for the Week of January 18, 2026

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

Russia’s Biosimilar Powerhouse: BIOCAD’s Patent Pipeline and the Oncology Disruption No One in the West Is Watching
Pharm to Table: Map Supply Chains and Predict Drug Shortages Using Patent Data
Read the Drug Patent Clock Before the Market Does: A step-by-step technical guide to forecasting pharmaceutical drug patent expiry for IP teams, R&D strategists, and institutional investors
Drug Market Entry Intelligence: The Definitive Guide for Pharma Strategists, IP Teams, and Institutional Investors
The Generic Drug Approval Process: A Complete Technical and Strategic Reference for Pharma IP, R&D, and Investment Teams

Popular Posts

Maximizing Pharmaceutical Patent Longevity: A Mechanistic and Strategic Guide to IP Term Extension and Lifecycle Fortification
Read the Drug Patent Clock Before the Market Does: A step-by-step technical guide to forecasting pharmaceutical drug patent expiry for IP teams, R&D strategists, and institutional investors
China’s Irreplaceable Role in the Global Generic Drug API Supply Chain (2026 Report)
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
Biotech’s $400B Problem: The Patent, IP, and Competitive Intelligence Playbook Every Pharma Executive Needs
M&A in Generic Drug Development: IP Valuation, Patent Strategy, and Dealmaking Intelligence
Stop the Clock: How Divisional Patents Block Cheaper Meds in Europe
Pharmaceutical Parallel Trade and Patent Term Arbitrage: The Complete IP Strategy Guide
How to bypass the GLP-1 patent lock
Divisional Patent Minefields: How Big Pharma Builds Legal Fortresses Around Blockbuster Drugs

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address